Free tool
FAERS Monitor: Maxidex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 013422 or its brand name (Maxidex, Dexamethasone). Reports on generic versions are filed under their own applications.
Reports
296,229
Serious
250,852
85% of reports
Hospitalization
114,249
Death reported
48,093
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use22,720
- fatigue17,522
- diarrhoea17,329
- plasma cell myeloma14,404
- nausea14,227
- pneumonia13,830
- death13,374
- drug ineffective13,237
- neutropenia11,785
- pyrexia11,130
- thrombocytopenia10,776
- dyspnoea10,408
- febrile neutropenia9,209
- anaemia9,128
- vomiting8,911
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,568 |
| 2005 | 2,141 |
| 2006 | 1,107 |
| 2007 | 891 |
| 2008 | 1,328 |
| 2009 | 1,942 |
| 2010 | 3,611 |
| 2011 | 5,411 |
| 2012 | 6,731 |
| 2013 | 6,747 |
| 2014 | 8,373 |
| 2015 | 17,419 |
| 2016 | 15,878 |
| 2017 | 17,891 |
| 2018 | 23,348 |
| 2019 | 23,301 |
| 2020 | 25,281 |
| 2021 | 28,980 |
| 2022 | 27,311 |
| 2023 | 24,185 |
| 2024 | 21,496 |
| 2025 | 18,480 |
| 2026 | 12,807 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,757,930 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| plasma cell myelomaSignal | 14,404 | 40.9 | 40.1 | 354,931 |
| febrile neutropeniaSignal | 9,209 | 11.3 | 11.0 | 74,562 |
| thrombocytopeniaSignal | 10,776 | 7.5 | 7.3 | 54,806 |
| neutropeniaSignal | 11,785 | 6.6 | 6.5 | 51,928 |
| anaemiaSignal | 9,128 | 3.5 | 3.4 | 15,810 |
| pneumoniaSignal | 13,830 | 3.1 | 3.1 | 19,412 |
| pyrexiaSignal | 11,130 | 2.3 | 2.3 | 8,282 |
| diarrhoea | 17,329 | 1.9 | 1.9 | 7,810 |
| off label use | 22,720 | 1.9 | 1.8 | 9,259 |
| fatigue | 17,522 | 1.6 | 1.6 | 4,129 |
| vomiting | 8,911 | 1.4 | 1.3 | 821 |
| dyspnoea | 10,408 | 1.3 | 1.3 | 775 |
| nausea | 14,227 | 1.3 | 1.3 | 897 |
| death | 13,374 | 1.1 | 1.1 | 134 |
| drug ineffective | 13,237 | 0.7 | 0.7 | 1,653 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.